Løndalen, A., Blakkisrud, J., Revheim, M., Madsbu, U. E., Dahle, J., Kolstad, A., & Stokke, C. (2020). FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of (177)Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma. Eur J Nucl Med Mol Imaging.

Løndalen, Ayca, Johan Blakkisrud, Mona-Elisabeth Revheim, Ulf Erik Madsbu, Jostein Dahle, Arne Kolstad, och Caroline Stokke. "FDG PET/CT Parameters and Correlations With Tumor-absorbed Doses in a Phase 1 Trial of (177)Lu-lilotomab Satetraxetan for Treatment of Relapsed Non-Hodgkin Lymphoma." Eur J Nucl Med Mol Imaging 2020.

Løndalen, Ayca, et al. "FDG PET/CT Parameters and Correlations With Tumor-absorbed Doses in a Phase 1 Trial of (177)Lu-lilotomab Satetraxetan for Treatment of Relapsed Non-Hodgkin Lymphoma." Eur J Nucl Med Mol Imaging 2020.